Speakers 2018

The World Health Summit brings together leading researchers, physicians, government officials and representatives from industry, non-governmental organizations (NGOs) and health care systems worldwide.

Among the confirmed speakers are:
(in alphabetical order)

  • All
  • B
  • G
  • H
  • J
  • K
  • O
  • P
  • Y
Seth Berkley, CEO, Gavi, the Vaccine Alliance

Seth Berkley

CEO, Gavi, the Vaccine Alliance, Switzerland

Seth Berkley is Gavi’s CEO and d medical doctor specializing in infectious disease epidemiology. He founded the International AIDS Vaccine Initiative (IAVI) in 1996, where he served as President and CEO. Prior to that, he worked for the Health Sciences Division at The Rockefeller Foundation, held posts at the Center for Infectious Diseases, the US Centers for Disease Control; the Massachusetts Department of Public Health; and the Carter Center, where he was assigned as an epidemiologist to the Ministry of Health in Uganda. 

Hélène Boisjoly, Dean, University of Montreal, Canada

Hélène Boisjoly

Dean, Faculty of Medicine, University of Montreal, Canada

An accomplished Corneal Surgeon and Ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at the University of Montreal and within the greater province of Quebec. She was the International President of the World Health Summit 2017.

Diane Gashumba, Minister of Health, Rwanda

Diane Gashumba

Minister of Health, Rwanda

Diane Gashumba is the Rwandan Minister of Health of the Republic of Rwanda since October 4, 2016. From March 29, 2016, she served as the Minister of Gender and Family Promotion. She is a pediatrician by profession bringing in much experience in global maternal, newborn and child health with focus to gender issues. She was Director of two district hospitals and President of the National Women Council, thus bringing in strong experience in empowering women.

Harald zur Hausen, Nobel Prize laureate, Physiology or Medicine, Germany (c) DKFZ

Harald zur Hausen

Nobel Prize laureate, Physiology or Medicine, Germany

From 1983 until 2003, Harald zur Hausen was appointed as Scientific Director of the Deutsches Krebsforschungszentrum (German Cancer Research Center) in Heidelberg. He demonstrated in 1983 that cervical cancer in humans is caused by certain types of papilloma viruses (wart viruses), the genes from which are incorporated into the host cells' DNA. This discovery made it possible to develop a vaccine against cervical cancer, which had been the second most common tumor disease in women. For his discovery, he was awarded the Nobel Prize in 2008.

Adnan Ali Hyder, Program Director, Health Systems, Johns Hopkins Bloomberg School of Public Health, USA

Adnan Ali Hyder

Program Director, Health Systems, Johns Hopkins Bloomberg School of Public Health, USA

Adnan Hyder is Professor and Associate Chair in the Department of International Health. He is the Director of the Health Systems program, Director of the International Injury Research Unit, and Associate Director of Global Programs at the Johns Hopkins Berman Institute of Bioethics. He serves as Co-Director of the NIH-Fogarty International Research Ethics Training Program at the Bloomberg School of Public Health.

Zsuzsanna Jakab, Regional Director for Europe, WHO

Zsuzsanna Jakab

Regional Director for Europe, WHO

Zsuzsanna Jakab has engaged first hand with many partners and WHO member states, contributing to the formulation of a joint health agenda for the WHO European Region and working for the WHO Europe in a range of senior management roles. Between 2002 and 2005, she was State Secretary at the Hungarian Ministry of Health, Social and Family Affairs. Prior to that, she served as the founding Director of the European Union's European Centre for Disease Prevention and Control in Stockholm, Sweden.

Ilona Kickbusch, Director, Global Health Programme, Graduate Institute of International and Development Studies, Geneva

Ilona Kickbusch

Director, Global Health Program, Graduate Institute, Switzerland

As a leading contributor to academic and political debates on governance for health at a national and global level, Ilona Kickbusch conducts global health diplomacy seminars in many regions and advises the World Health Organization (WHO). In Switzerland, she serves on the executive board of the Careum Foundation and as an advisor for Health 2020.

Stefan Oschmann, CEO, Merck, Germany

Stefan Oschmann

CEO, Merck, Germany

Stefan Oschmann is Chairman of the Executive Board and CEO of Merck. Before taking office at the end of April 2016, he served as Vice Chairman and Deputy CEO, with responsibility for Group Strategy, among other things. He joined Merck in 2011 as a member of the Executive Board and was responsible for the Healthcare business sector until the end of 2014. Before joining Merck, he worked for the U.S. pharma company MSD, where he served in a range of senior executive positions. 

Peter Piot, Director, LSHTM

Peter Piot

Director, London School of Hygiene & Tropical Medicine, UK

Peter Piot was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, as well as the Associate Director of the WHO Global Programme on AIDS. He was a co-discoverer of the Ebola virus, and his research focuses upon HIV/AIDS, sexually transmitted infections, and women’s health.

Naoko Yamamoto, Assistant Director-General for Universal Health Coverage and Health Systems Cluster, WHO

Naoko Yamamoto

Assistant Director-General for Universal Health Coverage and Health Systems Cluster, WHO

Naoko Yamamoto brings nearly 30 years of experience working on health in Japan and most recently served as Senior Assistant Minister for Global Heath in Japan’s Ministry of Health, Labor and Welfare. In this capacity, she was heavily involved in Japan’s Global Health leadership. Prior to this role, she served in numerous health-related positions within the government of Japan. She holds a medical degree, a PhD in epidemiology and a Masters in Public Health.